Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-11-10 Sale | 2025-11-13 4:13 pm | Pacira BioSciences Inc. | PCRX | Cross Shawn Chief Financial Officer | 12,060 | $22.09 | $266,405 | 56,250 (Direct) | View |
| 2023-12-27 Sale | 2023-12-28 5:29 pm | Applied Molecular Transport Inc. | AMTI | Cross Shawn CEO & Chair of the Board | 545,499 | $0 | $0 | 0 (Direct) | View |
| 2023-11-22 Sale | 2023-11-24 4:21 pm | Applied Molecular Transport Inc. | AMTI | Cross Shawn CEO & Chair of the Board | 110,802 | $0.1635 | $18,116 | 545,499 (Direct) | View |
| 2023-11-15 Sale | 2023-11-16 5:36 pm | Applied Molecular Transport Inc. | AMTI | Cross Shawn CEO & Chair of the Board | 90,447 | $0.1606 | $14,526 | 656,301 (Direct) | View |
| 2023-06-02 Sale | 2023-10-04 7:27 pm | Applied Molecular Transport Inc. | AMTI | Cross Shawn CEO & Chair of the Board | 5,559 | $0.23344 | $1,298 | 746,748 (Direct) | View |
| 2023-09-29 Sale | 2023-10-02 7:02 pm | Applied Molecular Transport Inc. | AMTI | Cross Shawn CEO & Chair of the Board | 193,960 | $0.1585 | $30,743 | 752,307 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 5:20 pm | Applied Molecular Transport Inc. | AMTI | Cross Shawn President & COO | 934 | $0.5 | $467 | 60,156 (Direct) | View |
| 2022-12-02 Sale | 2022-12-06 4:56 pm | Applied Molecular Transport Inc. | AMTI | Cross Shawn President & COO | 3,893 | $1.0501 | $4,088 | 61,090 (Direct) | View |
| 2022-09-01 Sale | 2022-09-06 7:17 pm | Applied Molecular Transport Inc. | AMTI | Cross Shawn President & COO | 884 | $1.4201 | $1,255 | 64,983 (Direct) | View |
| 2022-06-01 Sale | 2022-06-03 7:20 pm | Applied Molecular Transport Inc. | AMTI | Cross Shawn President & COO | 3,933 | $3.009 | $11,834 | 65,867 (Direct) | View |
| 2021-08-19 Sale | 2021-08-23 7:40 pm | Applied Molecular Transport Inc. | AMTI | Cross Shawn Chief Financial Officer | 10,000 | $30.12 | $301,193 | 609,700 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-10-31 Tax Withholding | 2025-11-03 5:41 pm | N/A N/A | Pacira BioSciences Inc. | PCRX | Cross Shawn Chief Financial Officer | 6,690 | $21.38 | 68,310 (Direct) | View |
| 2025-02-27 Option Award | 2025-03-03 11:44 am | N/A N/A | Cyclo Therapeutics Inc. | CYTH | Cross Shawn Director | 28,597 | $0 | 136,346 (Direct) | View |
| 2024-11-15 Option Award | 2024-11-18 2:10 pm | N/A N/A | Cyclo Therapeutics Inc. | CYTH | Cross Shawn Director | 17,228 | $0 | 107,749 (Direct) | View |
| 2024-11-04 Option Award | 2024-11-05 4:42 pm | N/A 2034-11-04 | Pacira BioSciences Inc. | PCRX | Cross Shawn Chief Financial Officer | 275,000 | $0 | 275,000 (Direct) | View |
| 2024-08-16 Option Award | 2024-08-20 1:49 pm | N/A N/A | Cyclo Therapeutics Inc. | CYTH | Cross Shawn Director | 9,028 | $0 | 90,521 (Direct) | View |
| 2024-06-03 Option Award | 2024-06-05 5:09 pm | N/A 2034-06-03 | Cyclo Therapeutics Inc. | CYTH | Cross Shawn Director | 24,449 | $0 | 97,055 (Direct) | View |
| 2023-12-27 Option Award | 2023-12-28 9:50 pm | 2023-12-27 2024-12-27 | Cyclo Therapeutics Inc. | CYTH | Cross Shawn Director | 161,516 | $0 | 162,516 (Direct) | View |
Ownership | 2023-12-28 9:48 pm | N/A N/A | Cyclo Therapeutics Inc. | CYTH | Cross Shawn Director | 0 | $0 | 0 (Direct) | View |
| 2023-09-28 Option Award | 2023-10-02 7:02 pm | N/A N/A | Applied Molecular Transport Inc. | AMTI | Cross Shawn CEO & Chair of the Board | 886,111 | $0 | 752,307 (Direct) | View |
| 2023-03-24 Option Award | 2023-03-27 9:11 pm | N/A 2033-03-23 | Applied Molecular Transport Inc. | AMTI | Cross Shawn CEO & Chair of the Board | 668,000 | $0 | 668,000 (Direct) | View |
| 2022-05-16 Option Award | 2022-05-18 6:07 pm | 2022-06-16 2032-05-16 | Applied Molecular Transport Inc. | AMTI | Cross Shawn President & COO | 102,000 | $0 | 153,750 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-16 7:57 pm | 2022-03-15 2032-02-15 | Applied Molecular Transport Inc. | AMTI | Cross Shawn Chief Financial Officer | 114,750 | $0 | 146,250 (Direct) | View |
| 2021-12-24 Option Award | 2022-01-06 7:22 pm | N/A N/A | Applied Molecular Transport Inc. | AMTI | Cross Shawn Chief Financial Officer | 31,500 | $0 | 31,500 (Direct) | View |
| 2021-08-19 Exercise | 2021-08-23 7:40 pm | N/A N/A | Applied Molecular Transport Inc. | AMTI | Cross Shawn Chief Financial Officer | 10,000 | $4.61 | 609,700 (Direct) | View |
| 2021-08-19 Exercise | 2021-08-23 7:40 pm | 2021-03-12 2030-03-20 | Applied Molecular Transport Inc. | AMTI | Cross Shawn Chief Financial Officer | 10,000 | $0 | 609,700 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 7:00 pm | 2021-04-01 2031-03-01 | Applied Molecular Transport Inc. | AMTI | Cross Shawn Chief Financial Officer | 63,000 | $0 | 63,000 (Direct) | View |